Entelexo offers a new approach to treating diseases by focusing on the patients, analyzing patterns, and utilizing data to optimize product efficacy.
Our engineered exosomes communicate with multiple, specific types of diseased cells simultaneously. This represents a logical step forward in treatment strategy, where for the first time the scope of novel treatments are capable of matching the natural complexities of diseases. Our rational engineering platform enables us to rapidly create and fine tune indication-specific exosome treatments.
Company Details
- Employees
- 2
- Founded
- 2020
- Address
- Irvine, Ca, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.entelexo.com
- Keywords
- Drug Development, Research & Development, Cellular Engineering, Exosome Engineering, Biotechnology, Pharmaceuticals, Therapeutics, Genetic Engineering, Protein Engineering, Disease Pathology.
- HQ
- Irvine, CA
Entelexo Biotherapeutics Questions
Entelexo Biotherapeutics's website is http://www.entelexo.com
Entelexo Biotherapeutics's LinkedIn profile is https://www.linkedin.com/company/entelexo
Entelexo Biotherapeutics has
2 employees.
View email and phone details for 2
employees at Entelexo Biotherapeutics.
Entelexo Biotherapeutics's industry is
Pharmaceutical Manufacturing
Entelexo Biotherapeutics's top competitors are
Arvetas Biosciences,
The Churchill Center,
Pbs Biotech,
Genetex, Inc.,
Endocyclic Therapeutics,
Invitrx Therapeutics,
Lumitron Technologies Inc.,
Barbados Ventures,
Amberstone Biosciences,
Judith A Purcell Dds Pc.
Entelexo Biotherapeutics's categories are Pharmaceutical Manufacturing
Entelexo Biotherapeutics's founding year is 2020
